EUVIMEDEUVIMED entdecken
Crossref

Prediction of 1 cm dose-equivalent rate on the day after administration of 177Lu-DOTATATE from 111In-somatostatine receptor scintigraphy prior to treatment

Go Takai, Kohei Hanaoka, Keiji Nagano, Tsutomu Okada, Maya Honda, Izumi Komoto

Annals of Nuclear Medicine · 2024-11 · 38 (11) · 927-932

DOI: 10.1007/s12149-024-01962-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Nuclear Medicine, online erschienen am 26.07.2024. Verfasst von Go Takai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan. takai.go@b4.kepco.co.jp. Hauptthemen laut MEDLINE: Octreotide, Organometallic Compounds, Receptors, Somatostatin, Indium Radioisotopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: When patients administered 177Lu-DOTATATE are released or discharged from rooms where radiopharmaceuticals are used, the time required for release or discharge varies across patients. This study investigated whether the amount of radioactivity accumulated on 111In-somatostatine receptor scintigraphy (111In-SRS) performed prior to treatment can predict the 1 cm dose-equivalent rate at a distance of 1 m from the patient on the day after 177Lu-DOTATATE administration. METHODS: Whole-body planar 111In-SRS images were acquired for 21 patients. Pixel values within whole-body and abdominal (35 × 25 cm) regions of interest (ROIs) were converted to radioactivity dose (MBq). The 1 cm dose-equivalent rate (µSv/h) at a distance of 1 m from the patient 18.3 ± 0.5 h after administration of 177Lu-DOTATATE was measured using an ionization survey meter. RESULTS: The following relationships were observed between the radioactivity on 111In-SRS and the 1 cm dose-equivalent rate on the day after administration of 177Lu-DOTATATE: whole-body ROI: y = 0.16x + 5.01 (r = 0.56, p = 0.009), abdominal ROI: y = 0.27x + 5.13 (r = 0.63, p = 0.002). The regression equations indicate that patients cannot be released or discharged from the radiopharmaceutical room the day after 177Lu-DOTATATE administration if the whole-body and abdominal ROI doses are greater than 81 and 48 MBq, respectively, on 111In-SRS. CONCLUSIONS: The amount of radioactivity accumulated on 111In-SRS may be a predictor of release criteria for patients receiving 177Lu-DOTATATE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OctreotideOrganometallic CompoundsReceptors, SomatostatinIndium RadioisotopesHumansMaleFemaleMiddle AgedAgedAdultRadiation DosageRadionuclide ImagingTime Factors

Stichwörter der Autor:innen

111In-somatostatine receptor scintigraphy177Lu-DOTATATE1 cm dose-equivalent ratePrediction factor

Substanzen

Octreotidelutetium Lu 177 dotatateOrganometallic CompoundsReceptors, SomatostatinIndium RadioisotopesIndium-111

Autor:innen und Institutionen

  • Department of Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan. takai.go@b4.kepco.co.jp.
  • Division of Positron Emission Tomography, Institute of Advanced Clinical Medicine, Kindai University Hospital, 377-2 Ohno-Higashi, Osakasayama, Osaka, 589-8511, Japan.
  • Department of Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.
  • Department of Diagnostic Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.
  • Department of Surgery, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-Ku, Osaka-Shi, Osaka, 5530003, Japan.

Zitieren

APA

Takai, G., Hanaoka, K., Nagano, K., Okada, T., Honda, M., & Komoto, I. (2024). Prediction of 1 cm dose-equivalent rate on the day after administration of 177Lu-DOTATATE from 111In-somatostatine receptor scintigraphy prior to treatment. Annals of Nuclear Medicine, 38(11), 927-932. https://doi.org/10.1007/s12149-024-01962-0

Vancouver

Takai G, Hanaoka K, Nagano K, Okada T, Honda M, Komoto I. Prediction of 1 cm dose-equivalent rate on the day after administration of 177Lu-DOTATATE from 111In-somatostatine receptor scintigraphy prior to treatment. Annals of Nuclear Medicine. 2024;38(11):927-932. doi:10.1007/s12149-024-01962-0

BibTeX
@article{Takai2024,
  author = {Takai, Go and Hanaoka, Kohei and Nagano, Keiji and Okada, Tsutomu and Honda, Maya and Komoto, Izumi},
  title = {Prediction of 1 cm dose-equivalent rate on the day after administration of 177Lu-DOTATATE from 111In-somatostatine receptor scintigraphy prior to treatment},
  journal = {Annals of Nuclear Medicine},
  year = {2024},
  volume = {38},
  number = {11},
  pages = {927--932},
  doi = {10.1007/s12149-024-01962-0}
}
Kostenlos starten →